Axcelis Technologies (ACLS) Projected to Post Earnings on Tuesday

Axcelis Technologies (NASDAQ:ACLS) is projected to release its Q2 2025 earnings data before the market opens on Tuesday, August 5th. Analysts expect Axcelis Technologies to post earnings of $0.73 per share and revenue of $185.15 million for the quarter. Axcelis Technologies has set its Q2 2025 guidance at 0.730-0.730 EPS.

Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings results on Tuesday, May 6th. The semiconductor company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.39 by $0.65. Axcelis Technologies had a return on equity of 18.55% and a net margin of 18.58%. The business had revenue of $192.56 million for the quarter, compared to analyst estimates of $184.86 million. During the same quarter in the previous year, the firm earned $1.57 EPS. Axcelis Technologies’s quarterly revenue was down 23.7% on a year-over-year basis. On average, analysts expect Axcelis Technologies to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Axcelis Technologies Stock Performance

Axcelis Technologies stock opened at $68.75 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 5.56 and a quick ratio of 4.08. Axcelis Technologies has a 52-week low of $40.40 and a 52-week high of $117.57. The firm has a market capitalization of $2.21 billion, a P/E ratio of 12.59 and a beta of 1.58. The stock has a fifty day moving average price of $68.61 and a two-hundred day moving average price of $61.30.

Analysts Set New Price Targets

Separately, B. Riley raised their target price on shares of Axcelis Technologies from $58.00 to $75.00 and gave the company a “neutral” rating in a research report on Wednesday, June 18th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $90.00.

Insider Transactions at Axcelis Technologies

In other Axcelis Technologies news, Director John T. Kurtzweil sold 1,682 shares of the firm’s stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $61.93, for a total value of $104,166.26. Following the completion of the transaction, the director directly owned 35,050 shares in the company, valued at $2,170,646.50. This trade represents a 4.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.48% of the company’s stock.

Institutional Investors Weigh In On Axcelis Technologies

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Goldman Sachs Group Inc. grew its stake in shares of Axcelis Technologies by 7.5% in the first quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock valued at $31,560,000 after buying an additional 44,275 shares in the last quarter. Royal Bank of Canada lifted its stake in Axcelis Technologies by 3.8% in the first quarter. Royal Bank of Canada now owns 117,566 shares of the semiconductor company’s stock valued at $5,838,000 after acquiring an additional 4,324 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Axcelis Technologies by 4.9% in the 1st quarter. AQR Capital Management LLC now owns 35,717 shares of the semiconductor company’s stock valued at $1,774,000 after acquiring an additional 1,678 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Axcelis Technologies by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,396 shares of the semiconductor company’s stock worth $963,000 after purchasing an additional 849 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Axcelis Technologies by 1.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 78,756 shares of the semiconductor company’s stock valued at $3,912,000 after purchasing an additional 836 shares during the period. Institutional investors own 89.98% of the company’s stock.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.